Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 9/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.47 |
| ▸ | HPGD | P15428 | 5/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | STAT1 | P42224 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4769837 | 0.85 | GAA (0.53) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL3655453 | 0.83 | SMN1; SMN2 (0.52) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL1921366 | 0.83 | GAA (0.51) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL22978462 | 0.82 | CYP1A2 (0.64) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL8101107 | 0.80 | SMN1; SMN2 (0.49) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL20843728 | 0.80 | L3MBTL1 (0.52) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL15348811 | 0.78 | GAA (0.64) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL20843703 | 0.77 | L3MBTL1 (0.56) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL1921112 | 0.76 | SMN1; SMN2 (0.59) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL27723934 | 0.75 | SMN1; SMN2 (0.55) | GAAL3MBTL1RAB9ASMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1460079-B1 | DIHYDROXY(3-PYRIDYL)BORANE COMPOUNDS | KOEI CHEMICAL CO (JP) | 2011-06-01 | — | — | EP | disclosed |
| US-7053079-B2 | Dihydroxy (3-pyridyl) borane compounds | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2006-05-30 | — | — | US | disclosed |
| US-20040254076-A1 | Dihydroxy (3-pyridyl) borane compounds | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1460079-A1 | DIHYDROXY(3-PYRIDYL)BORANE COMPOUNDS | Koei Chemical Co., Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254076-A1 | Dihydroxy (3-pyridyl) borane compounds | CYP24A1, DRD3, HSD3B1 | GAA 4343/4885L3MBTL1 2282/4885RAB9A 445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.